Lynwood Capital Management »

Pfizer shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Pfizer

Tip: Access up to 7 years of quarterly data

All positions including Pfizer held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pfizer by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $42k 1.5k 27.75
2023-06-30 $1.8M 50k 36.68

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp (BCTX)
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp (MAG)
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Pfizer

Vanguard Group
BlackRock
Wellington Management Company
Charles Schwab Investment Management
Geode Capital Management
Morgan Stanley
Massachusetts Financial Services
Susquehanna International
Northern Trust
Bank of America Corporation
State Farm Mutual Automobile Insurance Company
Legal & General Group
Citadel Advisors
Amundi
Bank of New York Mellon

View all funds holding Pfizer